WallStreetZenWallStreetZen

NASDAQ: BDRX
Biodexa Pharmaceuticals PLC Stock Forecast, Predictions & Price Target

Analyst price target for BDRX

Based on 1 analyst offering 12 month price targets for Biodexa Pharmaceuticals PLC.
Min Forecast
$8.00+966.67%
Avg Forecast
$8.00+966.67%
Max Forecast
$8.00+966.67%

Should I buy or sell BDRX stock?

Based on 1 analyst offering ratings for Biodexa Pharmaceuticals PLC.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BDRX stock forecasts and price targets.

BDRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-08

1 of 1

BDRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BDRX$0.75$8.00+966.67%Strong Buy
CMND$1.21N/AN/A
VRPX$3.17N/AN/A
ADTX$2.37N/AN/A
FNCH$2.30N/AN/A

Biodexa Pharmaceuticals Stock Forecast FAQ

Is Biodexa Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BDRX) stock is to Strong Buy BDRX stock.

Out of 1 analyst, 1 (100%) are recommending BDRX as a Strong Buy, 0 (0%) are recommending BDRX as a Buy, 0 (0%) are recommending BDRX as a Hold, 0 (0%) are recommending BDRX as a Sell, and 0 (0%) are recommending BDRX as a Strong Sell.

If you're new to stock investing, here's how to buy Biodexa Pharmaceuticals stock.

What is BDRX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BDRX price target, the average BDRX price target is $8.00, with the highest BDRX stock price forecast at $8.00 and the lowest BDRX stock price forecast at $8.00.

The Wall Street analyst predicted that Biodexa Pharmaceuticals's share price could reach $8.00 by Feb 8, 2025. The average Biodexa Pharmaceuticals stock price prediction forecasts a potential upside of 966.67% from the current BDRX share price of $0.75.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.